BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31285265)

  • 1. Phosphomimetic substitution at Ser-33 of the chloroquine resistance transporter PfCRT reconstitutes drug responses in
    Sanchez CP; Moliner Cubel S; Nyboer B; Jankowska-Döllken M; Schaeffer-Reiss C; Ayoub D; Planelles G; Lanzer M
    J Biol Chem; 2019 Aug; 294(34):12766-12778. PubMed ID: 31285265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil-Sensitive Transport of Quinacrine and Methylene Blue via the Plasmodium falciparum Chloroquine Resistance Transporter Reduces the Parasite's Susceptibility to these Tricyclic Drugs.
    van Schalkwyk DA; Nash MN; Shafik SH; Summers RL; Lehane AM; Smith PJ; Martin RE
    J Infect Dis; 2016 Mar; 213(5):800-10. PubMed ID: 26503982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron is a substrate of the
    Bakouh N; Bellanca S; Nyboer B; Moliner Cubel S; Karim Z; Sanchez CP; Stein WD; Planelles G; Lanzer M
    J Biol Chem; 2017 Sep; 292(39):16109-16121. PubMed ID: 28768767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinine dimers are potent inhibitors of the Plasmodium falciparum chloroquine resistance transporter and are active against quinoline-resistant P. falciparum.
    Hrycyna CA; Summers RL; Lehane AM; Pires MM; Namanja H; Bohn K; Kuriakose J; Ferdig M; Henrich PP; Fidock DA; Kirk K; Chmielewski J; Martin RE
    ACS Chem Biol; 2014 Mar; 9(3):722-30. PubMed ID: 24369685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite's food vacuole and alter drug sensitivities.
    Pulcini S; Staines HM; Lee AH; Shafik SH; Bouyer G; Moore CM; Daley DA; Hoke MJ; Altenhofen LM; Painter HJ; Mu J; Ferguson DJ; Llinás M; Martin RE; Fidock DA; Cooper RA; Krishna S
    Sci Rep; 2015 Sep; 5():14552. PubMed ID: 26420308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.
    Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E
    ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT).
    Zishiri VK; Joshi MC; Hunter R; Chibale K; Smith PJ; Summers RL; Martin RE; Egan TJ
    J Med Chem; 2011 Oct; 54(19):6956-68. PubMed ID: 21875063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Halo Chloroquine Derivatives Overcome Plasmodium falciparum Chloroquine Resistance Transporter-Mediated Drug Resistance in P. falciparum.
    Edaye S; Tazoo D; Bohle DS; Georges E
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7891-3. PubMed ID: 26438496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sites.
    Bellanca S; Summers RL; Meyrath M; Dave A; Nash MN; Dittmer M; Sanchez CP; Stein WD; Martin RE; Lanzer M
    J Biol Chem; 2014 Dec; 289(52):36336-51. PubMed ID: 25378409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.
    Edaye S; Reiling SJ; Leimanis ML; Wunderlich J; Rohrbach P; Georges E
    Mol Biochem Parasitol; 2014 Jun; 195(1):34-42. PubMed ID: 24914817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope-specific IgG pools identify PfCRT monomer and homodimer polypeptides that are differentially phosphorylated at Ser
    Baakdah F; Georges E
    Biochem Biophys Res Commun; 2021 Jun; 557():261-266. PubMed ID: 33894412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial Genetic Modeling of pfcrt-Mediated Drug Resistance Evolution in Plasmodium falciparum.
    Gabryszewski SJ; Modchang C; Musset L; Chookajorn T; Fidock DA
    Mol Biol Evol; 2016 Jun; 33(6):1554-70. PubMed ID: 26908582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Comparison of 45 Naturally Occurring Isoforms of the Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT).
    Callaghan PS; Hassett MR; Roepe PD
    Biochemistry; 2015 Aug; 54(32):5083-94. PubMed ID: 26208441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance Transporter.
    Richards SN; Nash MN; Baker ES; Webster MW; Lehane AM; Shafik SH; Martin RE
    PLoS Pathog; 2016 Jul; 12(7):e1005725. PubMed ID: 27441371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum.
    Sanchez CP; Stein WD; Lanzer M
    Trends Parasitol; 2007 Jul; 23(7):332-9. PubMed ID: 17493873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and evolutionary analyses of the Plasmodium falciparum chloroquine resistance transporter.
    Coppée R; Sabbagh A; Clain J
    Sci Rep; 2020 Mar; 10(1):4842. PubMed ID: 32179795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for Regulation of Hemoglobin Metabolism and Intracellular Ionic Flux by the Plasmodium falciparum Chloroquine Resistance Transporter.
    Lee AH; Dhingra SK; Lewis IA; Singh MK; Siriwardana A; Dalal S; Rubiano K; Klein MS; Baska KS; Krishna S; Klemba M; Roepe PD; Llinás M; Garcia CRS; Fidock DA
    Sci Rep; 2018 Sep; 8(1):13578. PubMed ID: 30206341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of benzhydryl-based antiplasmodial agents possessing Plasmodium falciparum chloroquine resistance transporter (PfCRT) inhibitory activity.
    Relitti N; Federico S; Pozzetti L; Butini S; Lamponi S; Taramelli D; D'Alessandro S; Martin RE; Shafik SH; Summers RL; Babij SK; Habluetzel A; Tapanelli S; Caldelari R; Gemma S; Campiani G
    Eur J Med Chem; 2021 Apr; 215():113227. PubMed ID: 33601312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.
    Gomez GM; D'Arrigo G; Sanchez CP; Berger F; Wade RC; Lanzer M
    PLoS Pathog; 2023 Jun; 19(6):e1011436. PubMed ID: 37285379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PfCRT and its role in antimalarial drug resistance.
    Ecker A; Lehane AM; Clain J; Fidock DA
    Trends Parasitol; 2012 Nov; 28(11):504-14. PubMed ID: 23020971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.